April 25th 2024
A large cohort study demonstrated the validity and reliability of single-channel electro-oculography (EOG) for sleep-stage classification.
Perspectives on Emerging Data for the Use of Immunotherapy in the Treatment of Early-Stage Non-Small Cell Lung Cancer
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
A Managed Care Focus on Assessing the Armamentarium for Multiple Sclerosis to Better Individualize Treatment
1.5 Credits / Neurology
View More
The Promising Role of Novel and Emerging Therapies for Amyotrophic Lateral Sclerosis: Clinical and Managed Care Insights
1.0 Credit / Neurology
View More
Evolving Treatment Strategies in the Management of Pulmonary Arterial Hypertension: Key Insights for the Pharmacist, featuring a Patient Perspective
1.5 Credits / Pulmonology/Respiratory
View More
Advances in EGFR Exon 20 Insertion-Positive Non–Small Cell Lung Cancer: A Focus on Specialty Pharmacy Interventions
1.5 Credits / Oncology, Pulmonology/Respiratory
View More
Strategies for the Management and Treatment of ALS: The Value of Early Diagnosis and Clinical Intervention
3.0 Credits / Neurology
View More
Leveraging Managed Care to Optimize Best Practices in the Treatment of Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
1.0 Credit / Neurology
View More
Advances and Best Practices for Managed Care Pharmacists and the Treatment of Patients with Alpha-1 Antitrypsin Deficiency
1.0 Credit / Pulmonology/Respiratory
View More
Improving Outcomes and Quality of Care in Spinal Muscular Atrophy: Updates in Treatment Advances
2.0 Credits / Neurology
View More
New and Emerging Treatment Strategies for Myasthenia Gravis: The Role of the Specialty Pharmacist
1.0 Credit / Neurology
View More
Improving Treatment Access for Spinal Muscular Atrophy: How Managed Care Strategies Can Ease Clinical and Caregiver Burden
1.5 Credits / Neurology
View More
Assessing the Treatment Landscape for Multiple Sclerosis to Better Individualize Care
1.5 Credits / Neurology
View More
Should Lower Doses of Melatonin Be Used For Older Adults?
May 5th 2020Tabula Rasa HealthCare (NASDAQ:TRHC) is a leader in providing patient-specific, data-driven technology and solutions that enable healthcare organizations to optimize medication regimens to improve patient outcomes, reduce hospitalizations, lower healthcare costs and manage risk. Medication risk management is TRHC’s lead offering, and its cloud-based software applications provide solutions for a range of payers, providers and other healthcare organizations.
Read More
Compared with patients who have just sleep apnea syndrome (SAS), those with both SAS and restless leg syndrome were shown to exhibit a higher degree of insomnia-specific psychological symptoms, which may indicate the benefit of cognitive behavioral therapy in these populations, according to study findings.
Read More
Delayed School Start Times Shown to Increase Adolescent Sleep Duration, Study Finds
April 27th 2020Delayed school start times were shown to increase sleep duration among adolescents and lessen the need for catch-up sleep during the weekend, which may assist in addressing nationwide sleep deficits in these populations.
Read More
Patients With OSAHS at Higher Risk of Alzheimer Disease Biomarkers, Cognitive Decline
April 20th 2020Patients with obstructive sleep apnea–hypopnea syndrome (OSAHS) had significantly higher Alzheimer disease biomarkers in their plasma than those without the condition, which may explain the occurrence of cognitive decline in these populations, according to study findings.
Read More
Researchers Modify Sleep Apnea Machines to Ease Ventilator Shortage
April 15th 2020To help ease ventilator shortages resulting from the coronavirus disease 2019 pandemic, researchers at New York University’s Tandon School of Engineering were able to modify continuous positive airway pressure machines, used to treat patients with sleep apnea, into alternatives for mechanical ventilators.
Read More
More than a third of healthcare workers responding to the coronavirus disease 2019 (COVID-19) pandemic in China during its peak suffered from insomnia, with those reporting sleeplessness also more likely to feel depressed, anxious, and have stress-based trauma, according to study findings published today.
Read More
Workers With Excessive Daytime Sleepiness, OSA at Higher Risk of Occupational Accidents
April 9th 2020Employees with either obstructive sleep apnea or excessive daytime sleepiness were shown to be 2 times more likely to be involved in occupational incidents, highlighting the serious safety hazard posed by both conditions.
Read More
Sleep, Physician Burnout Linked Amid COVID-19 Pandemic
March 31st 2020Amid the coronavirus disease 2019 (COVID-19) pandemic, the American Academy of Sleep Medicine (AASM) has issued a position statement on the significance of sufficient sleep, which when impaired has been deemed a possible contributing factor to physician burnout.
Read More
FDA Accepts Filing for Investigational Narcolepsy Medication
March 26th 2020The FDA has accepted for filing with priority review Jazz Pharmaceuticals’ new drug application for JZP-258. The investigational medicine targets cataplexy and excessive daytime sleepiness associated with narcolepsy.
Read More
Impaired Sleep Duration, Quality in Infancy Associated With Behavioral Health Issues in Children
March 13th 2020Toddlers with reported diminished sleep duration and quality during infancy had a greater likelihood of emotional and behavioral problems, with associations proving strongest for internalizing and dysregulation symptoms, according to study findings.
Read More
Better Sleep Linked With Reduced Risk of CVD, Improved Weight Loss
March 4th 2020Improved sleep patterns were linked with potential risk reductions of heart attacks, strokes, and other cardiovascular diseases, with additional associations found in helping women achieve and maintain a healthier body weight, according to preliminary research to be presented at American Heart Association's Epidemiology and Prevention | Lifestyle and Cardiometabolic Health Scientific Sessions 2020.
Read More
Sleep Disorders Common in Patients With T1D, Review Shows
March 2nd 2020A new review article shows scientific studies have consistently identified links between sleep problems and health outcomes in patients with type 1 diabetes (T1D). Despite the apparent links, there are no screening recommendations related to sleep in patients with the disease.
Read More
Review Outlines Guidance for Military Personnel, Veterans With Sleep Disorders
February 20th 2020In 2019, the US Department of Defense (DoD) and Department of Veterans Affairs (VA) approved clinical practice guidelines regarding management and treatment of chronic insomnia disorder and obstructive sleep apnea in VA and DoD patients. The VA/DoD Evidence-Based Practice Work Group formulated the framework to enable more effective screening, treatment, and managements of these diseases, according to a review published in Annals of Internal Medicine.
Read More
Narcolepsy Monitoring App Shows Possible Effectiveness in Symptom Tracking, Study Says
February 16th 2020The Narcolepsy Monitor—a companion app for long-term narcolepsy symptom monitoring—may be a helpful tool for gaining insight into the individual burden of narcolepsy symptoms over time and may serve as a patient-reported outcome measure, according to study findings.
Read More
Addressing Sleep Issues in Children, Teens With Autism
February 13th 2020In new guidelines issued today by the American Academy of Neurology (AAN), researchers provide sleep intervention recommendations to families, neurologists, and other healthcare providers in making decisions on the best treatments available for children and teens with autism.
Read More
Untreated Obstructive Sleep Apnea Results in Higher Costs, Healthcare Utilization
February 1st 2020Medicare beneficiaries with untreated obstructive sleep apnea (OSA) have increased healthcare utilization (HCU) and costs across all points of service, according to results of a recent study published by the Journal of Clinical Sleep Medicine.
Read More
Tolerance Complicates Sleep Benefit From Medical Cannabis Among Patients With Chronic Pain, Insomnia
January 29th 2020Medical cannabis was found to exhibit an overall positive effect on maintaining nightime sleep in patients with chronic pain, but frequent use was associated with problems of both waking up at night and falling asleep, according to study findings.
Read More
Jazz Pharmaceuticals Submits NDA for Therapy to Treat Excessive Daytime Sleepiness
January 23rd 2020Jazz Pharmaceuticals announced today it had redeemed its priority review voucher to submit a New Drug Application to the FDA on January 21, 2020; the company seeks approval for JZP-258, an investigational medication to treat cataplexy and excessive daytime sleepiness in patients 7 years and older with narcolepsy.
Read More
Blood Testing May Prove Effective Metric for Adolescent Sleep Duration, Study Shows
January 15th 2020Sleep duration was found to reflect the profile of specific circulating microRNAs in the blood of school-aged children and adolescents, indicating the potential efficacy of a blood test to examine those at risk of negative health outcomes related to insufficient sleep, according to study findings.
Read More